Purinergic Signaling in Ovarian Carcinoma
Ovarian carcinoma (OC) is the most lethal gynecological cancer worldwide. Around 95% of patients exhibit recurrence five years after treatment; 80% experience recurrence within 18 months after first-line treatment, and progression-free survival rates have not changed over the past 40 years. New ther...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Tabriz University of Medical Sciences
2025-11-01
|
| Серии: | Advanced Pharmaceutical Bulletin |
| Предметы: | |
| Online-ссылка: | https://apb.tbzmed.ac.ir/PDF/apb-15-779.pdf |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|